RESISTANCE ANALYSES FOR LEDIPASVIR/SOFOSBUVIR CONTAINING REGIMENS IN PATIENTS INFECTED WITH CHRONIC HCVWHOHAVE ADVANCED LIVER DISEASE OR ARE POST LIVER TRANSPLANT (SOLAR-1 & 2 STUDIES)

被引：2
|
作者：
Charlton, M. [1 ]
Manns, M. [2 ]
Dvory-Sobol, H. [3 ]
Svarovskaia, E. [3 ]
Doehle, B. [3 ]
Arterburn, S. [3 ]
Yun, C. [3 ]
Brainard, D. M. [3 ]
Mchutchison, J. G. [3 ]
Miller, M. D. [3 ]
Mo, H. [3 ]
Afdhal, N. [4 ]
Mutimer, D. [5 ]
机构：
[1] Intermt Med Ctr, Murray, UT USA
[2] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[3] Gilead Sci, Foster City, CA USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] QE Hosp, NIHR Liver Biomed Res Unit, Birmingham, W Midlands, England
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01701-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS099
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 35 条
  • [31] Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies
    Poordad, Fred
    Terrault, Norah A.
    Alkhouri, Naim
    Tian, Wei
    Allen, Lee F.
    Rabinovitz, Mordechai
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2020, 2020
  • [32] IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis C Genotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience
    Lutchman, Glen A.
    Nguyen, Nghia H.
    Chang, Christine Y.
    Ahmed, Aijaz
    Daugherty, Tami
    Garcia, Gabriel
    Kumari, Radhka
    Kim, W. Ray
    Gupta, Soumi
    Doshi, Dilesh
    Nguyen, Mindie H.
    HEPATOLOGY, 2015, 62 : 797A - 798A
  • [33] Inhaled Corticosteroid Plus Long-Acting β2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies
    Watz, H.
    Ferguson, G. T.
    Gronke, L.
    Vob, F.
    Abrahams, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Baseline HCV NS5A resistance-associated variants do not impact SVR12 rates in non-cirrhotic and post-liver transplant patients with genotype 1 infection treated with daclatasvir and sofosbuvir with or without ribavirin for 12 weeks: An integrated analysis
    McPhee, Fiona
    Hernandez, Dennis
    Zhou, Nannan
    Ueland, Joseph
    Vellucci, Vincent
    Hartman-Neumann, Sandra
    Yang, Xiaoyan
    Han, Zhou
    Yu, Fei
    Yang, Rong
    Noviello, Stephanie
    HEPATOLOGY, 2015, 62 : 560A - 561A
  • [35] INHALED CORTICOSTEROID PLUS LONG-ACTING beta 2-AGONIST THERAPY IS OVERUSED IN THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POST HOC ANALYSES OF TWO 1-YEAR STUDIES
    Watz, H.
    Ferguson, G. T.
    Groenke, L.
    Voss, F.
    Abrahams, R.
    Buhl, R.
    THORAX, 2015, 70 : A137 - A137
1234